In this study, our findings provide novel evidence implicating KAT2B in the upregulation of the tumor suppressor gene NF2 in CCA cells, which is independent of the histone acetyltransferase activity of KAT2B. This evidence concerns the gene KAT2B and cholangiocarcinoma.